We contribute to society through state-of-the art non-clinical pharmacological research using our patented "STAM™ mice" technology
In order to develop new drugs, it is important to be able to accurately measure the effectiveness of drug candidates at a nonclinical trial stage.
Our "STAM™ mice" are disease model mice that more accurately reflect human pathology and therefore play a major role in pharmacology studies.
SERVICE
We support more than 600 pharmaceutical companies and bio-ventures in over 29 countries with our cutting-edge research and pharmacology studies.
SERVICE
Thanks to our extensive experience in various treatment fields, we are able to provide quick and decisive support for our client's pharmacological studies.
SERVICE
Our expert pathologists support the construction of experimental analysis systems, data acquisition and explanation of results, and maximize the information from the histology samples of pharmacology studies conducted by clients.
TRIAL
Clients are able to perform preliminary research using both blood samples and various other biospecimens from the disease model mice that SMC offer.
* AND logical operation in case of multiple words.
Model cases
ServicesUPDATE
The comparison of our STAM™ and other Fibrosis models
2020.02.13
We would like to introduced some animal models for liver fibrosis, along with our proprietary NASH-HCC model (STAMTM model).
UPDATE
Translational relevance in STAM™ model (NASH-HCC)
2020.02.05
One factor that must be considered when selecting models for pre-clinical research is translatability.
NEWS RELEASE
Can-Fite BioPharma’s publication on International Journal of Molecular Medicine
2020.01.29
SMC announces that Can-Fite BioPharma has published the results of a study using STAM™ model in International Journal of Molecular Medicine.
